Table 1 Anthropometric data and clinical features of the respondents to the survey
From: Pregnancy- and lactation-induced osteoporosis: a social-media-based survey
| Â | PLO | Control | p value |
|---|---|---|---|
n | 27 | 43 | Â |
Age (years)- mean (SD) | 36.2 (4.7) | 38.8 (4.3) | Â |
Smoking before pregnancy | 5 (19%) | 3 (7%) | 0.245 |
Menstrual irregularities | 9 (33%) | 19 (44%) | 0.455 |
Physical activity | |||
 Before pregnancy | 13 (48%) | 31 (72%) | 0.074 |
  Before pregnancy ≥2 hours/week | 10 (37%) | 29 (67%) | 0.015 |
 During pregnancy | 8 (30%) | 22 (51%) | 0.088 |
  During pregnancy ≥2 hours/week | 7 (11%) | 19 (44%) | 0.003 |
Calcium supplementation during pregnancy | 2 (7%) | 13 (30%) | 0.034 |
Vitamin D3 supplementation during pregnancy | 5 (19%) | 17 (40%) | 0.111 |
Enoxaparin use | 7 (26%) | 2 (7%) | 0.038 |
Steroid use | 2 (7%) | 5 (12%) | 0.698 |
Osteoporosis in family | 9 (33%) | 14 (33%) | 1 |
Fracture in family | 1 (4%) | 4 (9%) | 0.642 |
Lactation | 29 (96%) | 37 (86%) | 0.236 |
Dietary calcium intake (mg), mean (SD) | 486 (291) | 393 (220) | 0.17 |